Michael Connett

Partner

Location: California

Michael Connett is a partner at Siri & Glimstad LLP with extensive experience in complex civil litigation, including toxic tort and regulatory actions, and an emerging focus on class action.

Mr. Connett’s civil practice is focused on obtaining justice for individuals harmed by corporate negligence, misguided medical practices, and overreaching government mandates. He has successfully represented individuals and families who have suffered catastrophic injuries as a result of toxic substances, and has spearheaded groundbreaking litigation to challenge outdated chemical safety standards under the Toxic Substances Control Act.

Mr. Connett received his J.D., magna cum laude from Temple Law School, in 2011, where he received numerous academic honors and served as Editor-in-Chief of the Temple Law Review.

After law school, Mr. Connett served as a law clerk to the Honorable Judge Michael M. Baylson of the U.S. District Court for the Eastern District of Pennsylvania, and the Honorable Judge Franklin Van Antwerpen of the U.S. Court of Appeals for the Third Circuit.

Recent Representative Matters

Served as lead attorney for environmental health groups in precedent-setting case (Food & Water Watch v. EPA) that resulted in a federal court ordering the EPA to eliminate the “unreasonable risk” posed by fluoridation of drinking water.
Represented families of mesothelioma victims against a manufacturer of asbestos-contaminated talc, which resulted in over $50 million in settlements.
Successfully obtained over $20 million in settlements for two families in lawsuit against a global aerospace company for birth defects caused by occupational chemical exposures.
Spearheaded dozens of FOIA requests which unearthed emails documenting that federal health officials had suppressed a long-awaited government review on the health effects of fluoride.
Served as co-counsel to former EPA Deputy Administrator in cases addressing asbestos and PFAS (“forever chemicals”) under the Toxic Substances Control Act.

Appearances

Wall St. Journal | November 28, 2024